These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24188865)

  • 1. Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy.
    Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Munck Af Rosenschöld P; Petersen PM; Specht L
    Radiother Oncol; 2014 Mar; 110(3):441-7. PubMed ID: 24188865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
    Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma.
    Jørgensen AY; Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Rosenschöld PM; Petersen PM; Specht L
    Acta Oncol; 2013 Oct; 52(7):1559-65. PubMed ID: 24047340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.
    Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Ann Oncol; 2013 Aug; 24(8):2113-8. PubMed ID: 23619032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
    Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy.
    Campbell BA; Hornby C; Cunninghame J; Burns M; MacManus M; Ryan G; Lau E; Seymour JF; Wirth A
    Ann Oncol; 2012 May; 23(5):1259-1266. PubMed ID: 21980193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients.
    Weber DC; Johanson S; Peguret N; Cozzi L; Olsen DR
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):490-7. PubMed ID: 20800383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
    Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
    Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study.
    Schneider U; Sumila M; Robotka J; Weber D; Gruber G
    Radiat Oncol; 2014 Feb; 9():58. PubMed ID: 24548307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma.
    Maraldo MV; Jørgensen M; Brodin NP; Aznar MC; Vogelius IR; Petersen PM; Berthelsen AK; Christensen CB; Hjalgrim LL; Specht L
    Pediatr Blood Cancer; 2014 Apr; 61(4):717-22. PubMed ID: 24660228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy.
    Liu J; Ng D; Lee J; Stalley P; Hong A
    Radiat Oncol; 2016 Mar; 11():34. PubMed ID: 26935470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study.
    Weber DC; Peguret N; Dipasquale G; Cozzi L
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1578-86. PubMed ID: 19596171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
    Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.
    Sachsman S; Hoppe BS; Mendenhall NP; Holtzman A; Li Z; Slayton W; Joyce M; Sandler E; Flampouri S
    Leuk Lymphoma; 2015 Jul; 56(7):2019-24. PubMed ID: 25315071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes.
    Zwahlen DR; Bischoff LI; Gruber G; Sumila M; Schneider U
    Radiat Oncol; 2016 Nov; 11(1):149. PubMed ID: 27832799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
    Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
    Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric-modulated arc therapy (VMAT) versus 3D-conformal radiation therapy in supra-diaphragmatic Hodgkin's Lymphoma with mediastinal involvement: A dosimetric comparison.
    Higby C; Khafaga Y; Al-Shabanah M; Mousa A; Ilyas M; Nazer G; Khalil EM
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):163-8. PubMed ID: 27245145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy.
    Mulvihill DJ; McMichael K; Goyal S; Drachtman R; Weiss A; Khan AJ
    Radiother Oncol; 2014 Aug; 112(2):279-83. PubMed ID: 25082095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.